{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T00:29:08Z","timestamp":1759624148795,"version":"build-2065373602"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.ejogrb.2014.03.021","type":"journal-article","created":{"date-parts":[[2014,4,12]],"date-time":"2014-04-12T16:55:17Z","timestamp":1397321717000},"page":"48-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Influence of an oral contraceptive containing drospirenone on insulin sensitivity of healthy women"],"prefix":"10.1016","volume":"178","author":[{"given":"Angelo","family":"Cagnacci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Piacenti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata","family":"Zanin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjeza","family":"Xholli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Tirelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2014.03.021_bib0005","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nrm2391","article-title":"Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes","volume":"9","author":"Guilherme","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.ejogrb.2014.03.021_bib0010","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.contraception.2009.08.009","article-title":"Effect of continuous regimen of contraceptive combination of ethinylestradiol and drospirenone on lipid, carbohydrate and coagulation profiles","volume":"81","author":"Machado","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.ejogrb.2014.03.021_bib0015","first-page":"64","article-title":"Insulin resistance, secretion and metabolism in users of oral contraceptives","volume":"74","author":"Godsland","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2014.03.021_bib0020","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.beem.2012.09.004","article-title":"Characteristics and metabolic effects of estrogen and progestins contained in oral contraceptive pills","volume":"27","author":"Sitruk-Ware","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2014.03.021_bib0025","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.contraception.2008.09.002","article-title":"Insulin sensitivity and lipid metabolism with oral contraceptives containing chlormadinone acetate or desogestrel: a randomized trial","volume":"79","author":"Cagnacci","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.ejogrb.2014.03.021_bib0030","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.contraception.2012.07.005","article-title":"Body composition in lean women with polycystic ovary syndrome: effect of ethinyl estradiol and drospirenone combination","volume":"87","author":"Aydin","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.ejogrb.2014.03.021_bib0035","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.contraception.2010.02.009","article-title":"Effect of oral contraceptive containing ethinyl estradiol combined with drospirenone vs. desogestrel on clinical and biochemical parameters in patients with polycystic ovary syndrome","volume":"82","author":"Kriplani","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.ejogrb.2014.03.021_bib0040","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.fertnstert.2009.10.016","article-title":"Comparison of effects of 3mg drospirenone plus 20\u03bcg ethinyl estradiol alone or combined with metformin or cyproterone acetate on classic metabolic cardiovascular risk factors in nonobese women with polycystic ovary syndrome","volume":"94","author":"Fruzzetti","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2014.03.021_bib0045","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1530\/eje.0.1450281","article-title":"Insulin sensitivity in women: a comparison among values derived from intravenous glucose tolerance tests with different sampling frequency, oral glucose tolerance test or fasting","volume":"145","author":"Cagnacci","year":"2001","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ejogrb.2014.03.021_bib0050","first-page":"310","article-title":"American Diabetes Association Consensus Development Conference on Insulin Resistance","volume":"21","year":"1998","journal-title":"Diab Care"},{"key":"10.1016\/j.ejogrb.2014.03.021_bib0055","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.fertnstert.2005.01.085","article-title":"Diagnostic criteria for polycystic ovary syndrome: a reappraisal","volume":"83","author":"Azziz","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2014.03.021_bib0060","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1056\/NEJM199602083340607","article-title":"Hypertension and associated metabolic abnormalities. The role of insulin resistance and the sympathoadrenal system","volume":"334","author":"Reaven","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2014.03.021_bib0065","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1210\/jcem-72-3-642","article-title":"Intravenous glucose tolerance test-derived insulin sensitivity changes during the menstrual cycle","volume":"72","author":"Valdes","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2014.03.021_bib0070","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1210\/jcem-47-6-1387","article-title":"Insulin receptors during the menstrual cycle in normal women","volume":"47","author":"De Pirro","year":"1978","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2014.03.021_bib0075","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1210\/jcem-52-1-29","article-title":"Changes in insulin receptors during oral contraception","volume":"52","author":"De Pirro","year":"1981","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2014.03.021_bib0080","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.contraception.2003.11.003","article-title":"A randomized study on the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on lipid and lipoprotein metabolism over a period of 13 cycles","volume":"69","author":"Gaspard","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.ejogrb.2014.03.021_bib0085","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0010-7824(99)00107-9","article-title":"Metabolic and fibrinolytic response to changed insulin sensitivity in users of oral contraceptives","volume":"60","author":"Petersen","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.ejogrb.2014.03.021_bib0090","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1210\/jc.2003-030328","article-title":"Glucose metabolism and insulin resistance in women with polycystic ovary syndrome during therapy with oral contraceptive containing cyproterone acetate or desogestrel","volume":"88","author":"Cagnacci","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2014.03.021_bib0095","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.contraception.2005.05.021","article-title":"Effect on insulin sensitivity of Implanon vs. GnRH agonist in women with endometriosis","volume":"72","author":"Cagnacci","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.ejogrb.2014.03.021_bib0100","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.maturitas.2004.01.001","article-title":"Pharmacological profile of progestins","volume":"47","author":"Sitruk-Ware","year":"2004","journal-title":"Maturitas"},{"key":"10.1016\/j.ejogrb.2014.03.021_bib0105","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1210\/jcem-64-5-960","article-title":"Insulin resistance and decreased tolerance in powelifters ingesting anabolic steroids","volume":"64","author":"Cohen","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2014.03.021_bib0110","first-page":"265","article-title":"Induction of insulin resistance by estrogens and androgens","volume":"79","author":"Polderman","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2014.03.021_bib0115","first-page":"774","article-title":"Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis","volume":"18","author":"Dunaif","year":"1997","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ejogrb.2014.03.021_bib0120","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1093\/humrep\/13.10.2706","article-title":"Effects of two antiandrogen treatments on hirsutism and insulin sensitivity in women with polycystic ovary syndrome","volume":"13","author":"Dahlgren","year":"1998","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2014.03.021_bib0125","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1093\/humrep\/14.4.893","article-title":"Effect of ovarian suppression on glucose metabolism of young lean women with and without ovarian hyperandrogenism","volume":"14","author":"Cagnacci","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2014.03.021_bib0130","first-page":"952","article-title":"The insulin resistance in women with hyperandrogenism is partially reversed by antiandrogen treatment: evidence that androgens impair insulin action in women","volume":"81","author":"Moghetti","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2014.03.021_bib0135","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1210\/jc.2003-031158","article-title":"Drospirenone for the treatment of hirsute women with polycystic ovary syndrome: a clinical, endocrinological, metabolic pilot study","volume":"89","author":"Guido","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2014.03.021_bib0140","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.fertnstert.2009.05.044","article-title":"Polycystic ovary syndrome and cardiovascular risk in young patients treated with drospirenone-ethinylestradiol or contraceptive vaginal ring. A prospective, randomized, pilot study","volume":"94","author":"Battaglia","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2014.03.021_bib0145","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/humrep\/deq301","article-title":"The association between the combined oral contraceptive pill and insulin resistance, dysglycemia and dyslipidemia in women with polycystic ovary syndrome: a systematic review and meta-analysis of observational studies","volume":"26","author":"Halperin","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2014.03.021_bib0150","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/09513590701325731","article-title":"Influence of a new oral contraceptive with drospirenone on lipid metabolism","volume":"23","author":"Taneepanichskul","year":"2007","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ejogrb.2014.03.021_bib0155","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/S0002-9378(12)91811-6","article-title":"Update on the metabolic effects of steroidal contraceptives and their relationship to cardiovascular disease risk","volume":"170","author":"Godsland","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2014.03.021_bib0160","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jama.1993.03500040071040","article-title":"NIH consensus development panel on triglyceride, high density lipoprotein and coronary heart disease","volume":"269","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.ejogrb.2014.03.021_bib0165","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1056\/NEJMoa1111840","article-title":"Thrombotic stroke and myocardial infarction with hormonal contraception","volume":"366","author":"Lidegaard","year":"2012","journal-title":"N Engl J Med"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211514001717?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211514001717?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:31:14Z","timestamp":1759555874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211514001717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":33,"alternative-id":["S0301211514001717"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2014.03.021","relation":{},"ISSN":["0301-2115"],"issn-type":[{"type":"print","value":"0301-2115"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of an oral contraceptive containing drospirenone on insulin sensitivity of healthy women","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2014.03.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}